Evolus, Inc. Common Stock

EOLS

$7.42

Name : Evolus, Inc. Common Stock

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $491,117,696.00

EPSttm : -0.48

Evolus, Inc. Common Stock

$7.42

8.96%

$0.61

EOLS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.39

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.16

EPS Last/This Y

0.75

EPS This/Next Y

0.34

Price

7.43

Target Price

15.4

Analyst Recom

1.33

Performance Q

-7.48

Upside

-321.7%

Beta

1.35

Ticker: EOLS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	EOLS	7.49	0.02	0.66	17648
2026-10-14	EOLS	7.22	0.02	0.15	17647
2026-10-15	EOLS	7.57	0.02	0.07	17656
2026-10-16	EOLS	7.14	0.02	0.00	17651
2026-10-19	EOLS	7.36	0.01	5.43	16917
2026-10-20	EOLS	7.36	0.01	0.00	16999
2026-10-21	EOLS	7.41	0.01	0.00	17011
2026-10-22	EOLS	7.4	0.01	0.62	17013
2026-10-23	EOLS	7	0.01	0.20	17003
2026-10-26	EOLS	7.13	0.01	0.00	16991
2026-10-27	EOLS	7.36	0.01	0.00	16992
2026-10-28	EOLS	7.64	0.01	0.00	15993
2026-10-29	EOLS	7.5	0.01	0.00	15796
2026-10-30	EOLS	7.34	0.01	0.01	15806
2026-11-02	EOLS	7.16	0.01	0.91	15348
2026-11-03	EOLS	7.39	0.01	0.00	15368
2026-11-04	EOLS	7.46	0.01	0.00	15640
2026-11-05	EOLS	6.8	0.01	0.15	15691
2026-11-06	EOLS	6.8	0.01	0.00	15687
2026-11-09	EOLS	6.97	0.01	0.00	15692
2026-11-10	EOLS	6.8	0.01	0.00	15703
2026-11-11	EOLS	7.43	0.01	0.00	15725
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	EOLS	7.51	59.4	30.5	-0.05
2026-10-14	EOLS	7.22	59.4	30.5	-0.05
2026-10-15	EOLS	7.58	59.4	31.0	-0.05
2026-10-16	EOLS	7.09	54.3	30.2	-0.05
2026-10-19	EOLS	7.36	54.3	31.3	-0.05
2026-10-20	EOLS	7.36	54.3	31.3	-0.05
2026-10-21	EOLS	7.35	54.3	31.3	-0.05
2026-10-22	EOLS	7.40	54.3	30.9	-0.05
2026-10-23	EOLS	7.00	54.3	30.9	-0.05
2026-10-26	EOLS	7.18	54.3	31.1	-0.05
2026-10-27	EOLS	7.36	54.3	31.2	-0.05
2026-10-28	EOLS	7.64	54.3	31.6	-0.05
2026-10-29	EOLS	7.51	54.3	30.7	-0.05
2026-10-30	EOLS	7.35	54.3	30.7	-0.05
2026-11-02	EOLS	7.16	54.3	30.6	-0.05
2026-11-03	EOLS	7.37	54.3	30.9	-0.05
2026-11-04	EOLS	7.46	54.3	31.0	-0.05
2026-11-05	EOLS	6.80	54.3	29.9	-0.05
2026-11-06	EOLS	6.80	278.8	27.4	-0.05
2026-11-09	EOLS	6.98	278.8	27.7	-0.05
2026-11-10	EOLS	6.81	278.8	30.2	-0.05
2026-11-11	EOLS	7.43	278.8	31.7	-0.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	EOLS	-1.26	9.53	9.73
2026-10-14	EOLS	-1.26	9.53	9.73
2026-10-15	EOLS	-1.26	9.53	9.73
2026-10-16	EOLS	-1.26	9.53	9.73
2026-10-19	EOLS	-1.26	9.52	9.73
2026-10-20	EOLS	-1.26	9.52	9.73
2026-10-21	EOLS	-1.26	9.52	9.73
2026-10-22	EOLS	-1.26	9.52	9.73
2026-10-23	EOLS	-1.26	9.52	9.73
2026-10-26	EOLS	-1.26	7.86	9.73
2026-10-27	EOLS	-1.26	7.86	11.08
2026-10-28	EOLS	-1.26	7.86	11.08
2026-10-29	EOLS	-1.26	7.86	11.08
2026-10-30	EOLS	-1.26	7.86	11.08
2026-11-02	EOLS	-1.26	7.73	11.08
2026-11-03	EOLS	-1.26	7.73	11.08
2026-11-05	EOLS	-1.26	7.73	11.08
2026-11-06	EOLS	-1.26	7.73	11.08
2026-11-09	EOLS	-1.26	7.28	11.06
2026-11-10	EOLS	-1.26	7.28	11.06
2026-11-11	EOLS	-1.26	7.28	10.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

0.05

Avg. EPS Est. Next Quarter

Insider Transactions

-1.26

Institutional Transactions

7.28

Beta

1.35

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

58.3

Max Drawdown 5-Year %

-77.5

Target Price

15.4

P/E

Forward P/E

22.48

PEG

P/S

1.51

P/B

P/Free Cash Flow

EPS

-0.47

Average EPS Est. Cur. Y

-0.05

EPS Next Y. (Est.)

0.29

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.56

Relative Volume

1.36

Return on Equity vs Sector %

55.9

Return on Equity vs Industry %

75.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

31.7

◆ EOLS Healthcare

$7.42

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

7/25

Volume

3/15

Valuation

13/20

TP/AR

3/10

Options

7/10

RSI

51.3

Range 1M

64.7%

Sup Dist

10.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

25/30

Estimates

4/20

Inst/Vol

8/15

Options

8/10

EPS Yr

92.6%

EPS NY

1115.4%

52W%

63.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +57% upside

Quality

7/30

Valuation

11/30

Growth

18/25

Stability

6/10

LT Trend

2/5

Upside

+57%

Quality

EOLS — P/E HistoricalDrug Manufacturers - Specialty & Generic

Evolus, Inc. Common Stock

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 365

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

EOLS

Latest News

—

Caricamento notizie per EOLS…

stock quote shares EOLS – Evolus, Inc. Stock Price stock today

news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EOLS – Evolus, Inc. yahoo finance google finance

stock history EOLS – Evolus, Inc. invest stock market

stock prices EOLS premarket after hours

ticker EOLS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EOLS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y